Skip to main content
SpringerLink
Log in

Postmortem evaluation of cholesterol, triglyceride, and apolipoprotein levels

  • Original Article
  • Published:
International Journal of Legal Medicine Aims and scope Submit manuscript

Abstract

Cholesterol and triglyceride levels have been analyzed in the forensic setting and their values correlated with atherosclerotic lesions found at autopsy and histology. Nevertheless, the results of these investigations have provided diverging information on postmortem molecule stability and postmortem measurement reliability. The aim of this study was to determine triglycerides, total cholesterol, low-density and high-density lipoprotein cholesterol, apolipoprotein B100, and apolipoprotein A-I in antemortem and postmortem serum samples in a series of cases (N = 10, including cardiac and noncardiac deaths) that underwent forensic investigations and had both samples available, measure the same molecules in postmortem serum from femoral blood and pericardial and pleural fluids (N = 39, including cardiac and noncardiac deaths), and evaluate whether different levels of these molecules could be observed in cases characterized by different degrees of coronary artery atherosclerosis (N = 39, including cardiac and noncardiac deaths). Preliminary results indicated that total cholesterol and low-density and high-density lipoprotein cholesterol levels in postmortem serum samples tended to be lower than those in antemortem specimens, whereas triglyceride levels in postmortem serum samples tended to be higher than those in antemortem samples. No relationship could be found between postmortem serum and pericardial fluid levels or between postmortem serum and pleural fluid levels of all tested biomarkers. Lastly, cases characterized by severe coronary artery atherosclerosis revealed higher postmortem serum levels of total cholesterol and apolipoprotein B. Globally considered, these data confirm that femoral blood postmortem serum levels of cholesterol and apolipoproteins may be considered suitable to estimate their antemortem values in forensic cases characterized by coronary artery atherosclerosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Miller M, Stone NJ, Ballantyne C, Bittner V, Criqui MH, Ginsberg HN, Goldberg AC, Howard WJ, Jacobson MS, Kris-Etherton PM, Lennie TA, Levi M, Mazzone T, Pennathur S, American Heart Association Clinical Lipidology, Thrombosis, and Prevention Committee of the Council on Nutrition, Physical Activity, and Metabolism, Council on Arteriosclerosis, Thrombosis and Vascular Biology, Council on Cardiovascular Nursing, Council on the Kidney in Cardiovascular Disease (2011) Triglycerides and cardiovascular disease. A scientific statement from the American Heart Association. Circulation 123(20):2292–2333

    Article  PubMed  Google Scholar 

  2. Patsch JR, Miesenböck G, Hopferwieser T, Mühlberger V, Knapp E, Dunn JK, Gotto AM Jr, Patsch W (1992) Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler Thromb 12(11):1336–1345

    Article  CAS  PubMed  Google Scholar 

  3. Harchaoui KE, Visser ME, Kastelein JJ, Stroes ES, Dallinga-Thie GM (2009) Triglycerides and cardiovascular risk. Curr Cardiol Rev 5(3):216–222

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Ozturk IC, Killeen AA (1999) An overview of genetic factors influencing plasma lipid levels and coronary artery disease risk. Arch Pathol Lab Med 123(12):1219–1222

    CAS  PubMed  Google Scholar 

  5. McBride P (2008) Triglycerides and risk for coronary artery disease. Curr Atheroscler Rep 10(5):386–390

    Article  CAS  PubMed  Google Scholar 

  6. Talayero BG, Sacks FM (2011) The role of triglycerides in atherosclerosis. Curr Cardiol Rep 13(6):544–552

    Article  PubMed  PubMed Central  Google Scholar 

  7. Ramasamy I (2014) Recent advances in physiological lipoprotein metabolism. Clin Chem Lab Med 52(12):1695–1727

    Article  CAS  PubMed  Google Scholar 

  8. Bitzur R, Cohen H, Kamari Y, Shaish A, Harats D (2009) Triglycerides and HDL cholesterol: stars or second leads in diabetes ? Diabetes Care 32(Suppl 2):S373–S377

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Rashid I, Klimis H, Duflou J, Sullivan D, Puranik R (2014) Utility of post-mortem lipid levels in fatal premature CAD: an autopsy study. Int J Cardiol 174(1):212–214

    Article  CAS  PubMed  Google Scholar 

  10. Freedman DS, Wattigney WA, Srinivasan S, Newman WP 3rd, Tracy RE, Byers T, Berenson GS (1993) The relation of atherosclerotic lesions to antemortem and postmortem lipid levels: the Bogalusa Heart Study. Atherosclerosis 104(1–2):37–46

    Article  CAS  PubMed  Google Scholar 

  11. Hornick CA, Baker HN, Malcom GT, Newman WP, Roheim PS, Strong JP (1988) Lipoproteins and apolipoproteins in postmortem serum. Mod Pathol 1(6):480–484

    CAS  PubMed  Google Scholar 

  12. Särkioja T, Ylä-Herttuala S, Solakivi T, Nikkari T, Hirvonen J (1988) Stability of plasma total cholesterol, triglycerides, and apolipoproteins B and A-I during the early postmortem period. J Forensic Sci 33(6):1432–1438

    Article  PubMed  Google Scholar 

  13. Valenzuela A, Hougen HP, Villanueva E (1994) Lipoproteins and apolipoproteins in pericardial fluid: new postmortem markers for coronary atherosclerosis. Forensic Sci Int 66(2):81–88

    Article  CAS  PubMed  Google Scholar 

  14. Coe JI (1993) Postmortem chemistry update. Emphasis on forensic application. Am J Forensic Med Pathol 14(2):91–117

    Article  CAS  PubMed  Google Scholar 

  15. Coe JI (1977) Postmortem chemistry of blood, cerebrospinal fluid, and vitreous humor. Leg Med Annu 1976:55–92

    CAS  PubMed  Google Scholar 

  16. Naumann HN (1956) Postmortem liver function tests. Am J Clin Pathol 26(5):495–505

    Article  CAS  PubMed  Google Scholar 

  17. Glanville JN (1960) Post-mortem serum cholesterol levels. Br Med J 2(5216):1852–1853

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Enticknap JB (1960) Biochemical changes in cadaver sera. J Forensic Med 7:135–146

    CAS  Google Scholar 

  19. Enticknap JB (1961) Lipids in cadaver sera after fatal heart attack. J Clin Pathol 14:496–499

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Enticknap JB (1962) Fatty acid content of cadaver sera in fatal ischemic heart disease. Clin Sci 23:425–431

    Google Scholar 

  21. Fekete JF, Brundson DFV (1974) The use of routine laboratory tests in postmortem examinations. Can Soc Forensic Sci J 70:238–254

    Article  Google Scholar 

  22. Sturner WQ (1971) Postmortem lipid studies: attempts to correlate with death from arteriosclerotic heart disease in the young age group. For Sci Gaz 2(1):5–7

    Google Scholar 

  23. Leadbeatter S, Stansbie D (1984) Postmortem diagnosis of familial hypercholesterolemia. Br Med (Clin Res Ed) 289(6459):1656

    Article  CAS  Google Scholar 

  24. Hart AP, Zumwalt RE, Dasgupta A (1997) Postmortem lipid levels for the analysis of the risk factors of sudden death: usefulness of the Ektachem and Monarch analyzers. Am J Forensic Med Pathol 18(4):354–359

    Article  CAS  PubMed  Google Scholar 

  25. Uemura K, Shintani-Ishida K, Saka K, Nakajima M, Ikegaya H, Kikuchi Y, Yoshida K (2008) Biochemical blood markers and sampling sites in forensic autopsy. J Forensic Legal Med 15(5):312–317

    Article  Google Scholar 

  26. Hiserodt JC, Perper JA, Koehler SA, Orchard TJ (1995) A comparison of blood lipid and lipoprotein values in young adults who die suddenly and unexpectedly from atherosclerotic coronary artery disease with other noncardiac deaths. Am J Forensic Med Pathol 16(2):101–106

    Article  CAS  PubMed  Google Scholar 

  27. Takeichi S, Nakajima Y, Osawa M, Yukawa N, Saito T, Seto Y, Nakano T, Adachi M, Jitsukata K, Horiuchi K, Wang T, Nakajima K (1997) The possible role of remnant-like particles as a risk factor for sudden cardiac death. Int J Legal Med 110(4):213–219

    Article  CAS  PubMed  Google Scholar 

  28. Takeichi S, Yukawa N, Nakajima Y, Osawa M, Saito T, Seto Y, Nakano T, Saniabadi AR, Adachi M, Wang T, Nakajima K (1999) Association of plasma triglyceride-rich lipoprotein remnants with coronary atherosclerosis in cases of sudden cardiac death. Atherosclerosis 142(2):309–315

    Article  CAS  PubMed  Google Scholar 

  29. Takeichi S, Nakajima Y, Yukawa N, Saito T, Seto Y, Huang XL, Kusakabe T, Jin ZB, Hasegawa I, Nakano T, Saniabadi A, Adachi M, Ohara N, Wang T, Nakajima K (2001) Plasma triglyceride-rich lipoprotein remnants as a risk factor of ‘Pokkuri disease’. Leg Med (Tokyo) 3(2):84–94

    Article  CAS  Google Scholar 

  30. Takeichi S, Nakajima Y, Yukawa N, Fujita MQ, Saito T, Satoh F, Seto Y, Kusakabe T, Jin ZB, Hasegawa I, Nakano T, Saniabadi A, Adachi M, Ohara N, Usui S, Okazaki M, Nakajima K (2004) Validity of plasma remnant lipoproteins as surrogate markers of antemortem level in cases of sudden coronary death. Clin Chim Acta 343(1–2):93–103

    Article  CAS  PubMed  Google Scholar 

  31. Nakajima Y, Takeichi S, Osawa M, Nakajima K, Nakano T, Fujita MQ (2006) The lipid and lipoprotein profiles of apo B-carrying particles in remnant-like lipoproteins isolated from plasma in sudden cardiac death cases. Tokai J Exp Clin Med 31(4):160–166

    CAS  PubMed  Google Scholar 

  32. Nakajima K, Nakajima Y, Takeichi S, Fujita MQ (2007) ApoB-100 carrying lipoprotein, but not apoB-48, is the major subset of proatherogenic remnant-like lipoprotein particles detected in plasma of sudden cardiac death cases. Atherosclerosis 194(2):473–482

    Article  CAS  PubMed  Google Scholar 

  33. Tsuji A, Ikeda N, Nakamura T (1999) Plasma lipids, lipoproteins and apolipoproteins and sudden cardiac death. Int J Legal Med 112(3):151–154

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

This study was not financially supported.

Author information

Authors and Affiliations

  1. CURML, University Center of Legal Medicine, Lausanne University Hospital, Chemin de la Vulliette 4, 1000, Lausanne, Switzerland

    Charlotte Girard, Maria Pia Scarpelli & Cristian Palmiere

  2. Department of Legal Medicine, University of Genova, Via de Toni 12, Genoa, Italy

    Camilla Tettamanti

Authors
  1. Charlotte Girard
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maria Pia Scarpelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Camilla Tettamanti
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Cristian Palmiere
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Cristian Palmiere.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Girard, C., Scarpelli, M.P., Tettamanti, C. et al. Postmortem evaluation of cholesterol, triglyceride, and apolipoprotein levels. Int J Legal Med 131, 1777–1782 (2017). https://doi.org/10.1007/s00414-017-1669-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00414-017-1669-4

Keywords

Search

Navigation